Keyphrases
Ovarian Cancer
100%
Preclinical Evaluation
100%
DNA Hypomethylating Agents
100%
Hypomethylating Agents
40%
Cancer Model
40%
IC50
40%
Differentially Expressed Genes
40%
Aldehyde Dehydrogenase 2 (ALDH2)
40%
Ferroptosis
40%
Unsaturated Fatty Acids
40%
Oxidized Lipids
40%
Stearoyl-coenzyme A Desaturase
40%
Patient-derived Xenograft
20%
Xenograft
20%
Cell Population
20%
DNA Methylation (DNAm)
20%
Chemotherapy
20%
Transcription Factor
20%
RNA Sequencing (RNA-seq)
20%
Cell Death
20%
Cancer Stem Cells
20%
Epigenetics
20%
Molecular Function
20%
Cell Viability
20%
Associated Genes
20%
Highly Sensitive
20%
Chemoresistance
20%
Ovarian Cancer Cells
20%
DNA Methyltransferase 1 (DNMT1)
20%
Lipid Homeostasis
20%
Tumor Suppressor
20%
Stemness
20%
Monotherapy
20%
Early Clinical Development
20%
Fatty Acid Biosynthesis
20%
Antitumor Effect
20%
Oleic Acid
20%
Cellular Expression
20%
Cell Stemness
20%
Lipid Analysis
20%
Cancer Cell Death
20%
SKOV3
20%
Deferoxamine
20%
Orally Bioavailable
20%
Tumor Differentiation
20%
Aldehyde Oxidoreductase
20%
Fallopian Tube Epithelial Cells
20%
Gene Ontology Enrichment Analysis
20%
Stimulated Raman Spectroscopy
20%
Cell Ferroptosis
20%
Identified Regulation
20%
Transcriptomic Reprogramming
20%
Biochemistry, Genetics and Molecular Biology
Ferroptosis
100%
Lipid
66%
Unsaturated Fatty Acid
66%
Cancer Cell
66%
IC50
66%
Cell Death
66%
Aldehyde Dehydrogenase
66%
Coenzyme A
66%
Cancer Model
66%
Differentially Expressed Gene
66%
Fatty Acid Synthesis
33%
Tumor Suppressor Protein
33%
Epigenetics
33%
RNA Sequence
33%
Transcriptomics
33%
Cell Viability
33%
DNA Methylation
33%
Reprogramming
33%
Lipid Homeostasis
33%
Low Drug Dose
33%
Oleic Acid
33%
Gene Ontology
33%
Lipidomics
33%
Transcription Factors
33%
Drug Resistance
33%
Cancer Stem Cell
33%
Oxidoreductase
33%
DNA Methyltransferase
33%
Medicine and Dentistry
Ovarian Cancer
100%
Hypomethylating Agent
100%
Ferroptosis
50%
Xenograft
33%
Cancer Cell
33%
Cancer Model
33%
Stearoyl-CoA
33%
Cell Death
33%
IC50
33%
Aldehyde Dehydrogenase
33%
Unsaturated Fatty Acid
33%
Epithelial Cell
16%
Monotherapy
16%
Low Drug Dose
16%
Oxidoreductase
16%
Fallopian Tube
16%
Cell Population
16%
DNA Methyltransferase
16%
Oleic Acid
16%
Cell Viability
16%
RNA Sequence
16%
Cancer Stem Cell
16%
Transcriptomics
16%
Raman Spectrometry
16%
Lipid Homeostasis
16%
Tumor Differentiation
16%
Lipidomics
16%
Transcription Factors
16%
Drug Resistance
16%
DNA Methylation
16%
Deferoxamine
16%
Fatty Acid Synthesis
16%
Tumor Suppressor Protein
16%
Pharmacology, Toxicology and Pharmaceutical Science
Ovary Cancer
100%
Ferroptosis
50%
Malignant Neoplasm
33%
Cancer Model
33%
Stearoyl-CoA
33%
IC50
33%
Aldehyde Dehydrogenase
33%
Unsaturated Fatty Acid
33%
Chemotherapy
16%
RNA-Sequencing
16%
Cell Viability
16%
Fatty Acid
16%
Oxidoreductase
16%
Tumor Suppressor Protein
16%
Deferoxamine
16%
DNA Methyltransferase
16%
Transcription Factors
16%
Drug Resistance
16%
Monotherapy
16%
Oleic Acid
16%